We are live on ! Find out more
TLSI icon

TriSalus Life Sciences

44 hedge funds and large institutions have $125M invested in TriSalus Life Sciences in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51.77% more ownership

Funds ownership: 0%51.77% (+52%)

Holders
44
Holders Change
+44
Holders Change %
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

TLSI Hedge Fund Activity: Q1 2021 in Review

44 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2021, worth a combined $125M.

Buyers outnumbered sellers: 44 funds opened new TLSI positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $27.9M.

  • 44 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $125M of TriSalus Life Sciences stock for Q1 2021.
  • 44 funds opened new TriSalus Life Sciences positions in Q1 2021 and 0 closed out, a net change of +44 holders.
  • The largest TriSalus Life Sciences buyer in Q1 2021 was BlackRock, an estimated $27.9M added.

Based on aggregated 13F filings for Q1 2021.